These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 699981)

  • 21. In vitro selectivity of lisuride and other ergot derivatives for alpha 1- and alpha 2-adrenoceptors.
    McPherson GA
    Eur J Pharmacol; 1984 Jan; 97(1-2):151-5. PubMed ID: 6321208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
    [No Abstract]   [Full Text] [Related]  

  • 23. Bromocriptine-induced hypothermia: D-2 receptor involvement.
    Zarrindast MR; Mahmoudi M
    Arch Int Pharmacodyn Ther; 1989; 298():38-49. PubMed ID: 2569299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the action of lysergic acid diethylamide and apomorphine on the copulatory response in the female rat.
    Eliasson M; Meyerson BJ
    Psychopharmacology (Berl); 1976 Sep; 49(3):301-6. PubMed ID: 826947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
    Oda T; Kume T; Izumi Y; Takada-Takatori Y; Niidome T; Akaike A
    Eur J Pharmacol; 2008 Nov; 598(1-3):27-31. PubMed ID: 18835264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central dopamine agonistic activity and microsomal biotransformation of lisuride, lergotrile and bromocriptine.
    Keller HH; Da Prada M
    Life Sci; 1979 Mar; 24(13):1211-21. PubMed ID: 36540
    [No Abstract]   [Full Text] [Related]  

  • 27. Lysergic acid diethylamide: evidence for stimulation of pituitary dopamine receptors.
    Meltzer HY; Fessler RG; Simonovic M; Doherty J; Fang VS
    Psychopharmacology (Berl); 1977 Aug; 54(1):39-44. PubMed ID: 143671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lisuride and LSD: dopaminergic and serotonergic interactions in the "serotonin syndrome".
    Silbergeld EK; Hruska RE
    Psychopharmacology (Berl); 1979 Nov; 65(3):233-7. PubMed ID: 117494
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of lisuride and LSD on monoamine synthesis after axotomy or reserpine treatment in rat brain.
    Kehr W; Speckenbach W
    Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):163-9. PubMed ID: 305542
    [No Abstract]   [Full Text] [Related]  

  • 30. Antagonism of a behavioral effect of LSD and lisuride in the cat.
    White FJ; Holohean AM; Appel JB
    Psychopharmacology (Berl); 1983; 80(1):83-4. PubMed ID: 6408677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminative stimulus properties of lergotrile.
    Cunningham KA; Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1984 Jul; 230(1):47-52. PubMed ID: 6146709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromocriptine and dopamine-receptor stimulation.
    Dray A; Oakley NR
    J Pharm Pharmacol; 1976 Jul; 28(7):586-8. PubMed ID: 8616
    [No Abstract]   [Full Text] [Related]  

  • 33. Potentiation of apomorphine-induced climbing behaviour in mice by d-LSD.
    Sovilla JY; Magistretti P; Schorderet M
    Prog Neuropsychopharmacol; 1979; 3(5-6):503-11. PubMed ID: 401002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The yawning behavior of rats following application of dopaminergic agonists--dose and time effect relationship].
    Stelzig S; Hoffmann W
    Pharmazie; 1988 Feb; 43(2):140-1. PubMed ID: 3393587
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies.
    White FJ; Wang RY
    J Pharmacol Exp Ther; 1984 Nov; 231(2):275-80. PubMed ID: 6491980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic drugs and ovulation: studies on PMS-induced ovulation and changes in median eminence DA and NE turnover in immature female rats.
    Agnati L; Fuxe K; Löfstöm A; Hökfelt T
    Adv Biochem Psychopharmacol; 1977; 16():159-68. PubMed ID: 883540
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of dopamine and serotonin in the discriminative stimulus effects of lisuride.
    White FJ; Appel JB
    J Pharmacol Exp Ther; 1982 May; 221(2):421-7. PubMed ID: 7077537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of dopamine, apomorphine and piribedil on the mesenterial blood flow of the cat.
    György L; Dóda M
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):22-32. PubMed ID: 4026462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system.
    Fink H; Morgenstern R
    Acta Biol Med Ger; 1980; 39(8-9):903-10. PubMed ID: 7282220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine agonists and audiogenic seizures: the relationship between protection against seizures and changes in monoamine metabolism.
    Anlezark GM; Horton RW; Meldrum BS
    Biochem Pharmacol; 1978; 27(24):2821-8. PubMed ID: 581645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.